Screener
Haemonetics HAE Goodwill
Goodwill at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | June 27, 2026 | March 28, 2026 |
|---|---|---|
| Total current assets | 810,832 | 834,879 |
| Property, plant and equipment, net | 303,778 | 305,761 |
| Intangible assets, less accumulated amortization of $374,828 as of June 27, 2026 and $363,763 as of March 28, 2026 | 434,512 | 447,655 |
| Goodwill | 656,884 | 656,368 |
| Deferred tax asset | 9,434 | 9,521 |
| Other long-term assets | 149,960 | 141,741 |
| Total assets | $2,365,400 | $2,395,925 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's goodwill?
- Haemonetics (HAE) reported goodwill of $656.88M in Q2 2026.
- How has Haemonetics's goodwill changed year-over-year?
- Haemonetics's goodwill increased by 8.2% year-over-year, from $607.3M to $656.88M.
- What is the long-term trend for Haemonetics's goodwill?
- Over 5 years (2021 to 2026), Haemonetics's goodwill has grown at a 7.1% compound annual growth rate (CAGR), from $466.44M to $656.37M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.
Ask your AI about Haemonetics's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude